Seth Feuerstein, MD, JD, serves as a Senior Advisor for Athyrium. Dr. Feuerstein has spent more than 25 years in healthcare and is a seasoned healthcare executive and entrepreneur. He has worked across every stage from startup, scale, acquisition and large corporate management. He has worked to develop, study and scale technologically-based innovations to enhance access, data collection, research and care in the medical ecosystem. Most recently he was Chief Innovation Officer and Chief Medical Officer at Magellan Health, a $7 billion health insurance company working in Medicaid/Medicare, PBM, Radiology, Cardiology and Behavioral Benefit Management.
Dr. Feuerstein is considered to be a global leader in the field of digital health, healthcare innovation and other related fields including addiction care and suicide prevention.
Dr. Feuerstein also serves as an advisor to NASA's Translational Research Institute for Space Health, on the part time faculty at the Yale School of Medicine, as the Director of the Yale Center for Digital Health, on the advisory board of the Yale Center for Biomedical and Interventional Technology, and as a psychiatrist for the Connecticut Department of Mental Health and Addiction Services. Dr. Feuerstein is actively involved in the community, having launched Little Wonder, a non-profit organization that supports cancer patients and their loved ones by leveraging technology to improve their treatment experience with positive non-treatment related events to drive improved personal and clinical outcomes. The program is currently working with 20 cancer centers.
Dr. Feuerstein received his bachelor's degree from Cornell University, his medical and law degrees from New York University, and completed his medical internship and residency at Yale University.